Evaluation of chemokine- and phlogistin-mediated leukocyte chemotaxis using an in vivo sponge model

Inflammation

Volumn 24, Issue 4, 2000, Pages 331-346

  Fine, Jay S ^a   Jackson, James V ^a   Rojas Triana, Alberto ^a   Bober, Loretta A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE KC; DEXAMETHASONE; EOTAXIN; INTERLEUKIN 10; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHLOGISTIN; PIROXICAM; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE MIGRATION; MACROPHAGE; MOUSE; NONHUMAN; SPONGE; T LYMPHOCYTE;

ANIMALS; CHEMOKINE CCL2; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; FEMALE; FLOW CYTOMETRY; INFLAMMATION; KINETICS; MICE; MODELS, BIOLOGICAL; SURGICAL SPONGES; ZYMOSAN;

ANIMALIA; MURINAE;

EID: 0034041302     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007044914240     Document Type: Article

References (40)

1. 1. BAGGIOLINI, M., B. DEWALD, and B. MOSER. 1997. Human chemokines: an update. Annu. Rev. Immunol., 15:675-705.
2. 2. LOCATI, M., and P. M. MURPHY. 1999. Chemokines and chemokine receptors. Biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med., 50:425-440.
3. 3. ZLOTNIK, A., J. MORALES, and J. A. HEDRICK. 1999. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol., 19:1-47.
4. 4 during experimental inflammation. Biochem. Pharmacol., 32:1353-1359.
5. 4 in the exudate of rat carrageenin-induced pleurisy. Prostaglandins, 26:493-504.
6. 4. polymorphonuclear leukocytes and inflammatory exudates in the rat. Prostaglandins, 28:13-27.
7. 7. GRIFFITHS, R. J., S. W. LI, B. E. WOOD, and A. BLACKHAM. 1991. A comparison of the anti-inflammatory activity of selective 5-lipoxygenase inhibitors with dexamethasone and colchicinc in a model of zymosan induced inflammation in the rat knee joint and peritoneal cavity. Agents Actions, 32:312-320.
8. 8. TADIMETI, S. R., J. L. CURRIE, A. F. SHAFFER, and P. C. ISAKSON. 1994. In vivo characterization of zymosan-induced mouse peritoneal inflammation. J. Pharmacol. Exp. Ther., 269:917-925.
9. 4 in zymosan-induced rat pleurisy: inhibition of leukocyte infiltration by the 5-lipoxygenase inhibitor T-0757. Biol. Pharm. Bull., 18:1302-1304.
10. 10. PAYA, M., M. C. TERENCIO, M. L. FERRANDIZ, and M. J. ALCARAZ. 1996. Involvement of secretory phospholipase A2 activity in the zymosan rat air pouch model of inflammation. Br. J. Pharmacol., 117:1773-1779.
11. 11. GARCIA-PASTOR, P., A. RANDAZZO, L. GOMEZ-PALOMA, M. J. ALCARAZ, and M. PAYA, M. 1999. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation. J. Pharmacol. Exp. Ther., 289:166-172.
12. 4 synthase activity in thioglycollate-elicited peritoneal macrophages. Biochem. Biophys. Res. Commun., 171:1344-1352.
13. 4 productivity in thioglycollate-elicited peritoneal macrophages. Prostaglandins Leukot. Essent. Fatty Acids, 40:109-115.
14. 14. FORD-HUTCHISON, A. W., J. R. WALKER, and J. H. SMITH. 1978. Assessment of anti-inflammatory activity by sponge implantation techniques. J. Pharmacol. Meth., 1:3-7.
15. 15. HAGEN, M., I. PAEGELOW, and P. LANGE. 1982. Assessment of chemotactic activity by means of implanted sponges. Allergie u. Immunol., 28:129-137.
16. 16. GARRETT, R., B. MANTHEY, B. VERNON-ROBETS, and P. M. BROOKS. 1983. Assessment of non-steroidal anti-inflammatory drug combinations by the polyurethane sponge implantation model in the rat. Annals Rheum. Dis., 42:439-442.
17. 17. MELLOR, D. M., D. B. MYERS, and V. S. CHADWICK. 1986. The cored sponge model of in vivo leucocyte chemotaxis. Agents Actions, 18:550-554.
18. 18. IUVONE, T., N. VAN OSSELAER, F. D'AQUISITO, R. CARNUCCIO, and A. G. HERMAN. 1997. Differential effect of L-NAME and S-methyl-isothiourea on leukocyte emigration in carrageeninsoaked sponge implants in the rat. Br. J. Pharmacol., 121:1637-1644.
19. 19. MIDDLETON, M. M., and P. A. CAMPBELL. 1989. Functions of purified mouse neutrophils isolated from gelatin sponges. J. Leukoc. Biol., 46:461-466.
20. 20. FINE, J. S., X.-Y. CAI, L. JUSTICE, C. P. GOMMOLL, L. D. HAMILTON, T. A. WATERS, S. K. NARULA, L. A. BOBER, and M. J. GRACE. 1997. A specific stimulator of granulocyte colony-stimulating factor accelerates recovery from cyclophosphamide-induced neutropenia in the mouse. Blood, 90:795-802.
21. 21. HERZENBERG, L. A., A. M. STALL, P. A. LALOR, C. SIDMAN, W. A. MOORE, D. R. PARKS, and L. A. HERZENBERG. 1986. The Ly-1 B cell lineage. Immunol. Rev., 93:81-102.
22. 22. HORI, Y., D.-E. Hu, H. YASUI, R. L. SMITHER, G. A. GRESHAM, and T. P. D. FAN. 1996. Differential effects of angiostatic steriods and dexamethasone on angiogenesis and cytokine levels in rat sponge implants. Br. J. Pharmacol., 118:1584-1591.
23. 23. MAJIMA, M., M. ISONO, Y. IKEDA, I. HAYASHI, K. HATANAKA, Y. HARADA, O. KATSUMATA, S. YAMASHINA, M. KATORI, and S. YAMAMOTO. 1997. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn. J. Pharmacol., 75:105-114.
24. 24. VALLERA, D. A., S. J. MENTZER, and S. E. MAIZEL. 1982. Tumor sponge implantation: an in vivo method for studying syngeneic primary antitumor lymphocyte responses. Cancer Res., 42:397-404.
25. 25. AKPORIAYE, E. T., C. A. BARBIERI, C. C. STEWART, and J. G. BENDER. 1991. Gelatin sponge model of effector recruitment: tumoricial activity of adherent and non-adherent lymphokine-activated killer cells after culture in int7erleukin-2. J. Leukoc. Biol., 49:189-196.
26. 26. FRADE, J. M., M. MELLADO, G. DEL REAL, J. C. GUTIERREZ-RAMOS, P. LIND, and C. MARTINEZ-Z. 1997. Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells. J. Immunol., 159:5576-5584.
27. 27. NAKAMURA, K., I. R. WILLIAMS, and T. S. KUPPER. 1995. Keratinocyte-derivcd monocyte chemoattractant protein 1 (MCP-1): analysis on a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol., 105:635-643.
28. 28. PONATH, P. D., S. X. QIN, D. J. RINGLER, I. CLARK-LEWIS, J. WANG, N. KASSAM, H. SMITH, X. J. SHI, J. A. GONZALO, W. NEWMAN, J. C. GUTIERREZ-RAMOS, and C. R. MACKAY. 1996. Cloning of the human cosinophol chemoattractant, eotaxin-expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest., 97:604-612.
29. 29. LIAO, F., R. L. RABIN, J. R. YANNELLI, L. G. KONIARIS, P. VANGURI, and J. M. FARBER. 1995. Human mig chemokine: biochemical and functional characterization. J. Exp. Med., 182:1301-1314.
30. 30. LOETSCHER, M., B. GERBER, P. LOETSCHER, S. A. JONES, L. PIALI, I. CLARK-LEWIS, M. BAGGIOLINI, and B. MOSER. 1996. Chemokine receptor specific for IP10 and Mig: structure, function and expression in activated T-lymphocytes. J. Exp. Med., 184:963-969.
31. 31. LOETSCHER, M., P. LOETSCHER, N. BRASS, E. MEESE, and B. MOSER. 1998. Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization. Eur. J. Immunol., 28:3696-3705.
32. 32. LOETSCHER, P., M. SEITZ, M. BAGGIOLINI, and B. MOSER. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med., 184:569-577.
33. 33. MOSMANN, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol., 56:1-26.
34. 34. KASAMA, T., R. M. STRIETER, N. W. LUKACS, M. D. BURDICK, and S. L. KUNKEL. 1994. Regulation of neutrophil-derived chemokine expression by interleukin-10. J. Immunol., 152:3559-3569.
35. 35. WANG, P., P. Wu, M. I. SIEGEL, R. W. EGAN, and M. M. BILLAH. 1994. Interleukin-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol., 153:811-816.
36. 36. BERKAN, N., M. JOHN, G. ROESEMS, G., P. J. JOSE, P. J. BARNES, and K. F. CHUNG. 1995. Inhibition of macrophage inflammatory protein-1α expression by IL-10. Differential sensitivities of human blood monocytes and alveolar macrophages. J. Immunol., 155:4412-4418.
37. 37. AJUEBOR, M. N., A. M. DAS, L. VIRAG, C. SZABO, and M. PERRETTI. 1999. Regulation of macrophage inflammatory protein-1α expression and function by endogenous interleukin-10 in a model of acute inflammation. Biochem. Biophys. Res. Commun., 255:279-282.
38. 38. KIM, H. S., D. ARMSTRONG, T. A. HAMILTON, and J. M. TEBO. 1998. IL-10 suppresses LPS-induced KC mRNA expression via a translation-dependent decrease in mRNA stability. J. Leukoc. Biol., 64:33-39.
39. 39. HORTON, M. R., M. D. BURDICK, R. M. STRIETER, C. BAO, and P. W. NOBLE. 1998. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-γ in mouse macrophages. J. Immunol., 160:3023-3030.
40. 40. ERLICH, L. C., S. Hu, P. K. PETERSON, and C. C. CHAO. 1998. IL-10 down-regulates human microglial IL-8 by inhibition of NF-κB activation. NeuroReport, 9:1723-1726.